Skip to main content

Please enter a keyword and click the arrow to search the site

Nicholas Piramal Limited - Intergrating Diversity


Strategy and Entrepreneurship, Strategy and Entrepreneurship

Publication Year



In rapidly deregulating markets, merger and acquisition driven growth represents one attractive strategic option. This option however comes with its well-known risks and dangers. Nicholas Piramal has grown phenomenally over the 1990's, emerging as a major pharmaceutical company in India, by adopting such a strategy. Over this decade, it has acquired the Indian operations of several well known pharmaceutical multinationals including Hoffman - La Roche, Boehringer Mannheim and the R&D unit of Hoechst. The case describes how the company has managed each of these acquisitions - all the way from the deal making to the post-acquisition integration phases. However, while the individual acquisitions only created the platform, sustained growth required that all the acquired units be integrated in an overall unified organisation. The case also describes how Nicholas Piramal developed such an organisation in 1997 and the structures, management processes and leadership it put in place to ensure effective functioning of the total company.

Topic List

Growth, Mergers & Acquistion, Strategies in emerging markets



Publication Event Date


LBS Case Number




Publication Organisation Size

$420 million in revenues

Project Funder


Available on ECCH


Select up to 4 programmes to compare

Select one more to compare
subscribe_image_desktop 5949B9BFE33243D782D1C7A17E3345D0

Sign up to receive our latest news and business thinking direct to your inbox